Trial Profile
Phase I trial of gentamicin formulations (LJPC-30Sa and LJPC-30Sb)
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 May 2015
Price :
$35
*
At a glance
- Drugs Gentamicin (Primary)
- Indications Bacterial infections; Cystic fibrosis-associated respiratory tract infections; Duchenne muscular dystrophy
- Focus Adverse reactions
- Sponsors La Jolla Pharmaceutical Company
- 11 May 2015 New trial record
- 07 May 2015 Following a pre-Investigational New Drug application meeting with the US FDA, La Jolla has received guidance that it may proceed with this proposed Phase I clinical trial following the submission of an IND, according to a media release.